GLS and cancer: Because the glutaminase enzymes are often highly expressed and activated in cancer (17, 18, 20, 54) and viral-infected host cells (13, 14, 38, 63), as compared to normal healthy cells, small molecule inhibitors targeting these enzymes offer a potentially safe therapeutic strategy.